Addington, D. E., Jones, B., Bloom, D., et al (1993) Reduction of hospital days in chronic schizophrenic patients treated with risperidone: A retrospective study. Clinical Therapeutics, 15, 917–926.
Burns, T., Raftery, J., Beadsmoore, A., et al (1993) A controlled trial of home-based acute psychiatric services. II: Treatment patterns and costs. British Journal of Psychiatry, 163, 55–61.
Carpenter, W. T., Conley, R. R., Buchanan, R. W., et al (1995) Patient response and resource management. Another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152, 827–832.
Carr-Hill, R. & Morris, J. (1991) Current practice in obtaining the ‘Q’ in QALYs: a cautionary note. British Medical Journal, 303, 699–701.
Davies, L. M. & Drummond, M. F. (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the UK. British Journal of Psychiatry, 162, 38–42.
Donaldson, C., Atkinson, K., Bond, J., et al (1988) Should QALYs be programme-specific?
Journal of Health Economics, 7, 239–257.
EuroQoL Group (1990) EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.
Goldberg, D. (1995) Cost-effectiveness studies in the valuation of mental health services in the community: current knowledge and problems. International Clinical Psychopharmacology, 9 (suppl. 5), 29–34.
Hallam, A., Beecham, J., Knapp, M., et al (1994) The costs of accommodation and care: Community provision for former long-stay psychiatric hospital patients. European Archives of Psychiatry and Clinical Neurosciences, 243, 304–310.
Kavanagh, S. (1993) Elderly people with cognitive impairment: Costing possible changes in the balance of care. Health and Social Care in the Community, 1, 69–80.
Kind, P. & Dolan, P. (1995) The effect of past and present illness experience on the valuation of health states. Medical Care, 33, AS255–AS263.
Knapp, M., Beecham, J., Anderson, J., et al (1990) The TAPS Project. 3: Predicting the community costs of closing psychiatric hospitals. British Journal of Psychiatry, 157, 661–670.
Knapp, M., Beecham, J., Koutsogeorgopoulou, V., et al (1994a) Service use and costs of home-based versus hospital-based care for people with serious mental illness. British Journal of Psychiatry, 165, 195–203.
Knapp, M., Cambridge, P., Thomason, C., et al (1994b) Residential care as an alternative to long-stay hospital: a cost-effectiveness evaluation of two pilot projects. International Journal of Geriatric Psychiatry, 9, 297–304.
Meltzer, H. Y., Cola, P., Way, L., et al (1993) Cost-effectiveness of clozapine in neuroleptic-resistant schizophrenia. American Journal of Psychiatry, 150, 1630–1638.
Mooney, G. (1989) QALYs: Are they enough? A health economist's perspective. Journal of Medical Ethics, 15, 148–152.
Rawles, J. M. (1989) Castigating QALYs. Journal of Medical Ethics, 15, 143–147.
Reid, W. H., Mason, M. & Toprac, M. (1994) Savings in hospital bed-days related to treatment with clozapine. Hospital and Community Psychiatry, 45, 261–263.
Rosenheck, R., Neale, M. & Frisman, L. (1995) Issues in estimating the cost of innovative mental health programs, Psychiatric Quarterly, 66, 9–31.
Wilkinson, G., Williams, B., Krekorian, H., et al (1992) QALYs in mental health: a case study. Psychological Medicine, 22, 725–731.